Blade Therapeutics

SPAC merger called off as company connected to ex-Purdue CEO decides to remain private
Endpoints
Mon, 06/13/22 - 09:47 pm
Blade Therapeutics
Purdue Pharma
SPAC
M&A
Small biotech chaired by ex-Purdue CEO Mark Timney jumps into the SPAC lane
Endpoints
Mon, 11/8/21 - 10:53 am
Mark Timney
SPAC
Blade Therapeutics
Purdue Pharma
Biotech Acquisition Company
Blade Therapeutics updates enrollment progress for Covid-19 pneumonia study of BLD-2660
Pharmaceutical Business Review
Thu, 08/13/20 - 09:49 am
Blade Therapeutics
clinical trials
BLD-2660
COVID-19
COVID-19 pneumonia